These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6831629)

  • 21. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapidly labelled synthesis of ribonucleic acid in Ehrlich ascites C-2 tumour cells treated with actinomycin D.
    Popović DA
    Nature; 1965 Oct; 208(5005):49-50. PubMed ID: 5895036
    [No Abstract]   [Full Text] [Related]  

  • 23. Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor.
    Skovsgaard T
    Cancer Res; 1980 Apr; 40(4):1077-83. PubMed ID: 7357538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II.
    Jensen PB; Jensen PS; Demant EJ; Friche E; Sørensen BS; Sehested M; Wassermann K; Vindeløv L; Westergaard O; Hansen HH
    Cancer Res; 1991 Oct; 51(19):5093-9. PubMed ID: 1655244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.
    Friche E; Skovsgaard T; Nissen NI
    Cancer Chemother Pharmacol; 1987; 19(1):35-9. PubMed ID: 3815723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
    Nielsen D; Maare C; Skovsgaard T
    Biochem Pharmacol; 1995 Aug; 50(4):443-50. PubMed ID: 7646548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro.
    Dano K; Frederiksen S; Hellung-Larsen P
    Cancer Res; 1972 Jun; 32(6):1307-14. PubMed ID: 5063994
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changes.
    Bouchelouche P; Friche E; Sehested M; Jensen PB; Skovsgaard T
    Biochem Pharmacol; 1991 Jan; 41(2):243-53. PubMed ID: 1899193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [RADIOAUTOGRAPHIC STUDIES ON THE UPTAKE OF H 3-ACTINOMYCIN BY MOUSE ASCITES TUMOR CELLS].
    BACKMANN R
    Verh Dtsch Ges Pathol; 1963; 47():271-5. PubMed ID: 14168367
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma.
    Murray SL; Du Vall EM; Slater LM
    Cancer Chemother Pharmacol; 1984; 13(1):69-70. PubMed ID: 6733845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcellular localization of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells.
    Londos-Gagliardi D; Aubel-Sadron G; Maral R; Trouet A
    Eur J Cancer (1965); 1980 Jun; 16(6):849-54. PubMed ID: 7408932
    [No Abstract]   [Full Text] [Related]  

  • 33. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T; Jensen PB; Demant EJ; Friche E; Bindslev N
    Br J Cancer; 1990 Jul; 62(1):37-41. PubMed ID: 1975202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 35. Daunorubicin inhibition of DNA-dependent RNA polymerases from Ehrlich ascites tumor cells.
    Barthelemy-Clavey V; Molinier C; Aubel-Sadron G; Maral R
    Eur J Biochem; 1976 Oct; 69(1):23-33. PubMed ID: 991857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor.
    Dano K
    Cancer Chemother Rep; 1971 Apr; 55(2):133-41. PubMed ID: 5118683
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nucleic acid synthesis in the cells of some ascites tumors induced by change in ionic homeostasis].
    Kaz'min SD
    Biokhimiia; 1981 Jul; 46(7):1226-35. PubMed ID: 7272352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells.
    Papahadjopoulos D; Poste G; Vail WJ; Biedler JL
    Cancer Res; 1976 Sep; 36(9 pt.1):2988-94. PubMed ID: 975068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lectin staining patterns of plasma membranes of daunorubicin and vincristine resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(6):366-70. PubMed ID: 2453973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.
    Dano K
    Cancer Chemother Rep; 1972 Dec; 56(6):701-8. PubMed ID: 4660629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.